Hydrochloric Acid → HCID 136366984, 화합물

반응식

[F:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[C:7]([C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=1[OH:18])[N:6]=[C:5]2[N:19]1[CH2:23][CH2:22][C@@H:21]([NH:24][C:25]([CH:27]2[CH2:29][CH2:28]2)=[O:26])[CH2:20]1.[ClH:30].CCOCC>C(Cl)Cl>[ClH:30].[F:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[C:7]([C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=1[OH:18])[N:6]=[C:5]2[N:19]1[CH2:23][CH2:22][C@@H:21]([NH:24][C:25]([CH:27]2[CH2:28][CH2:29]2)=[O:26])[CH2:20]1

참가 물질

실험 절차

To a solution of N-((R)-1-(6-fluoro-2-(2-hydroxyphenyl)quinazolin-4-yl)pyrrolidin-3-yl)cyclopropanecarboxamide (225 mg, 0.57 mmol) in 5 mL CH2Cl2 was added a 2 M HCl solution in ether (0.28 mL, 0.57 mmol), which resulted in the precipitation of a solid. After the addition of 20 mL ether, the reaction mixture was stirred for 1 h. The solvents were evaporated under reduced pressure to afford N-((R)-1-(6-fluoro-2-(2-hydroxyphenyl)quinazolin-4-yl)pyrrolidin-3-yl)cyclopropanecarboxamide hydrochloride (225 mg, 91%). LC/MS: m/z 393.3 (M+H)+ at 2.43 min (10%-99% CH3CN (0.035% TFA)/H2O (0.05% TFA)). 1H NMR (400 MHz, DMSO-d6) δ 8.23 (d, J=8.3 Hz, 1H), 8.04 (d, J=10.6 Hz, 1H), 7.91-7.94 (m, 1H), 7.79-7.83 (m, 1H), 7.44-7.48 (m, 1H), 7.00-7.03 (m, 2H), 4.44 (t, J=4.9 Hz, 1H), 4.09-4.23 (m, 3H), 3.87-3.90 (m, 1H), 2.25-2.34 (m, 1H), 2.02-2.09 (m, 1H), 1.49-1.55 (m, 1H), 0.68-0.71 (m, 4H).